ACTIV1: Master Protocol for Immune Modulars: Remdisivir in COVID 19 patients
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
DCRI-Duke-Site
Start Date
August 17, 2020
End Date
September 30, 2022
Administered By
Medicine, Infectious Diseases
Awarded By
DCRI-Duke-Site
Start Date
August 17, 2020
End Date
September 30, 2022